B. Riley Has Bearish Estimate for Celsius Q3 Earnings

Key Points

• B. Riley Brokers have reduced their Q3 2025 earnings per share estimate for Celsius Holdings to $0.20, down from $0.21, while maintaining a "Buy" rating and a target price of $75.00.
• Multiple analysts have varying ratings on Celsius, with Stifel Nicolaus increasing their target price to $70.00 and Wall Street Zen downgrading their rating from "buy" to "hold".
• Celsius stock has experienced significant insider selling, with CEO John Fieldly reducing his stake by 13.78% after selling over 143,000 shares in August.

Celsius Holdings Inc. (NASDAQ:CELH - Free Report) - Analysts at B. Riley reduced their Q3 2025 earnings estimates for shares of Celsius in a research note issued to investors on Tuesday, September 2nd. B. Riley analyst J. Van. Sinderen now forecasts that the company will earn $0.20 per share for the quarter, down from their prior estimate of $0.21. B. Riley has a "Buy" rating and a $75.00 price target on the stock. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. B. Riley also issued estimates for Celsius' Q4 2025 earnings at $0.13 EPS.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. The company had revenue of $739.30 million for the quarter, compared to analyst estimates of $632.13 million. Celsius had a net margin of 7.91% and a return on equity of 36.88%. Celsius's revenue was up 83.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.28 earnings per share.

Several other analysts have also recently issued reports on the stock. JPMorgan Chase & Co. increased their target price on shares of Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a research note on Thursday, July 31st. Stephens restated an "overweight" rating on shares of Celsius in a research report on Monday, August 11th. Bank of America raised their price objective on shares of Celsius from $35.00 to $40.00 and gave the company an "underperform" rating in a research report on Friday, August 8th. Maxim Group raised their price objective on shares of Celsius from $50.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Finally, TD Cowen upgraded shares of Celsius from a "hold" rating to a "buy" rating and raised their price objective for the company from $37.00 to $55.00 in a research report on Monday, June 16th. Seventeen analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Celsius currently has an average rating of "Moderate Buy" and an average target price of $59.89.

Celsius Stock Down 3.9%

Shares of NASDAQ:CELH traded down $2.39 during midday trading on Wednesday, hitting $58.37. 5,976,793 shares of the company's stock were exchanged, compared to its average volume of 6,431,793. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. The stock has a 50 day moving average price of $51.32 and a 200-day moving average price of $41.13. The company has a market cap of $15.06 billion, a PE ratio of 157.76, a price-to-earnings-growth ratio of 1.32 and a beta of 1.34. Celsius has a 12 month low of $21.10 and a 12 month high of $63.50.

Insider Transactions at Celsius

In other news, CEO John Fieldly sold 143,167 shares of the firm's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $51.18, for a total value of $7,327,287.06. Following the completion of the sale, the chief executive officer directly owned 895,410 shares of the company's stock, valued at approximately $45,827,083.80. This trade represents a 13.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder William H. Milmoe sold 100,000 shares of Celsius stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the transaction, the insider directly owned 17,717,770 shares of the company's stock, valued at approximately $841,594,075. This trade represents a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,123,641 shares of company stock worth $52,998,580. 2.55% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. ProShare Advisors LLC raised its holdings in Celsius by 3.9% in the second quarter. ProShare Advisors LLC now owns 6,970 shares of the company's stock worth $323,000 after buying an additional 261 shares during the last quarter. Blue Chip Partners LLC raised its holdings in Celsius by 2.4% in the second quarter. Blue Chip Partners LLC now owns 11,701 shares of the company's stock worth $543,000 after buying an additional 271 shares during the last quarter. Quadrant Capital Group LLC raised its holdings in Celsius by 1.6% in the second quarter. Quadrant Capital Group LLC now owns 18,221 shares of the company's stock worth $845,000 after buying an additional 279 shares during the last quarter. Spire Wealth Management raised its holdings in Celsius by 12.0% in the first quarter. Spire Wealth Management now owns 2,677 shares of the company's stock worth $95,000 after buying an additional 287 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC raised its holdings in Celsius by 3.2% in the first quarter. Wealthcare Advisory Partners LLC now owns 9,718 shares of the company's stock worth $346,000 after buying an additional 301 shares during the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.